...
首页> 外文期刊>Regenerative Therapy >Development of a bioanalytical method for circulating human T cells in animals using Arthrobacter luteus-based quantitative polymerase chain reaction and its application in preclinical biodistribution studies
【24h】

Development of a bioanalytical method for circulating human T cells in animals using Arthrobacter luteus-based quantitative polymerase chain reaction and its application in preclinical biodistribution studies

机译:基于叶绿酱的定量聚合酶链反应及其在临床前生物分布研究中的生物分析方法生物分析方法

获取原文
           

摘要

Introduction In the development of cell therapy products for human use, studies on the biodistribution of transplanted cells in animals are important for assessing the safety and efficacy of these products. Although a few reports have described the biodistribution of human cells in animals using Arthrobacter luteus -based-polymerase chain reaction (Alu-PCR), most have used genomic DNA or synthetic oligonucleotide as calibrators, as opposed to actual cells. In addition, bioanalytical variability in the quantification of cells with respect to specificity, selectivity, accuracy, and precision, has not been evaluated. Accordingly, in this study, we validated the utility of this bioanalytical method for human T cells in mice to establish assay performance using cells as a calibrator. Methods A standard curve was constructed for the addition of cell lysates to mouse tissues and blood, and DNA was extracted. Alu-PCR was applied for the quantification of human peripheral blood CD8 T cells in mice. To determine assay performance, we evaluated accuracy, precision, selectivity, specificity, and stability. In?vivo cell kinetics and biodistribution were investigated based on intravenous administration of human T cells to mice. Results Alu-PCR enabled us to specifically detect human T cells in mouse blood and tissues. The lower detection limit of Alu-PCR was 10?cells/15?mg tissue (7.5?mg for spleen and lung) or cells/50?μL blood. Given that PCR threshold cycle (Cq) values among mouse samples (blood, liver spleen, lung, heart, and kidney) show slight variation, calibration curves should be generated using the same tissue as used for the assay. Most coefficients of variation in the assay were within 30%. The cell kinetics of administered human T cells in mice were successfully evaluated using the established Alu-qPCR. Conclusions The Alu-PCR technique developed in this study showed sufficient specificity and sensitivity in detecting human peripheral blood CD8 T cells in mice. This technique, which targets the primate-specific Alu gene, is applicable for quantifying transplanted human cells in animals without the necessity of cell labeling. The data presented herein will be useful for standardizing bioanalytical approaches in biodistribution studies of cell therapy products.
机译:引言在开发用于人体使用的细胞疗法产品中,对动物移植细胞生物分布的研究对于评估这些产品的安全性和功效是重要的。虽然少数报告已经描述了使用促花杆菌 - 基于聚合酶链反应(Alu-PCR)的动物中人体细胞生物分布,但大多数使用基因组DNA或合成寡核苷酸作为校准剂,而不是实际细胞。此外,尚未评估相对于特异性,选择性,准确度和精度的细胞量化的生物分析可变性。因此,在本研究中,我们验证了这种生物分析方法对小鼠中的人T细胞的效用,使用细胞作为校准器建立测定性能。方法构建标准曲线以加入小鼠组织和血液的细胞裂解物,提取DNA。 Alu-PCR被施用于小鼠中人外周血CD8 T细胞的定量。为了确定测定性能,我们评估了准确性,精度,选择性,特异性和稳定性。基于静脉内施用人T细胞对小鼠进行研究,研究了体内细胞动力学和生物分布。结果Alu-PCR使我们能够在小鼠血液和组织中特别检测人T细胞。较低的Alu-PCR的检测限为10?细胞/15μmG组织(脾和肺的7.5×mg)或细胞/50μl血液。鉴于小鼠样品(血液,肝脏脾,肺,心脏和肾脏)之间的PCR阈值循环(CQ)值显示出轻微的变化,应使用与测定的相同组织产生校准曲线。测定中大多数变异系数在30%以内。使用已建立的Alu-QPCR成功评估小鼠中施用人T细胞的细胞动力学。结论本研究中开发的ALU-PCR技术表现出足够的特异性和敏感性在检测小鼠中的人外周血CD8 T细胞方面。该技术靶向灵长类动物特异性Alu基因,适用于量化动物中的移植的人细胞,而不需要细胞标记。本文提出的数据将用于标准化细胞疗法的生物分布研究中的生物分析方法。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号